Syngenta makes its IPO case as Q1 growth holds up despite geopolitics and trade disruption

Syngenta Group reported Q1 2026 sales of $6.4 billion and EBITDA of $1.4 billion, with improved margins driven by its focus on higher-quality, innovation-led agribusiness. Growth was led by strong performance in crop protection—especially in China and Europe—and solid momentum in seeds, supported by new technologies, AI, and biologicals. Despite ongoing geopolitical tensions, FX headwinds, and trade disruptions, Syngenta maintained steady growth and reinforced its transformation narrative ahead of a potential IPO. The company highlighted continued innovation, operational efficiencies, and portfolio simplification as key to its resilience and higher-margin strategy.